NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search

UCB Biosciences Inc.

UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis.

Company location

8010 Arco Corporate Drive, Suite 175
Raleigh, NC 27617

P.O. Box 110167
Research Triangle Park, NC 27709
Phone 
(919) 767-2555
Fax 
(919) 767-2570
County 
Wake
Region 
Triangle

Company Classification

Company type 
Bioscience Company
Year founded 
1928
Employment in NC 
200-499
US headquarters 
Georgia
Global headquarters 
Belgium
Company activities 
Research and Development
Products on market 
In the US, UCB markets Cimzia®, Briviact®, Keppra®, Keppra XR®, Vimpat®, Neupro®, Metadate CD®, Lortab®, and Tussionex® Pennkinetic® among other pharmaceuticals
Products under development 
Cimzia®, Briviact®, Vimpat® continue with new indication development. Romosozumab (osteoporosis) in Phase III, padsevonil (epilepsy), bimekizumab (arthritis/dermatology), rozanolixizumab (myasthenia gravis) and several other compounds in developmen.